.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Argus Health
UBS
US Army
Cerilliant
Queensland Health
Deloitte
Colorcon
US Department of Justice

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021483

« Back to Dashboard
NDA 021483 describes GEODON, which is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. It is available from twelve suppliers. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the GEODON profile page.

The generic ingredient in GEODON is ziprasidone hydrochloride. There are twenty-one drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the ziprasidone hydrochloride profile page.

Summary for NDA: 021483

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antipsychotics
Bipolar Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrengthEQ 10MG BASE/ML
Approval Date:Mar 29, 2006TE:RLD:No
Patent:► SubscribePatent Expiration:May 18, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:May 27, 2019Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATENT OF PSYCHOSIS
Patent:► SubscribePatent Expiration:Dec 18, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF BIPOLAR DISORDER

Expired Orange Book Patents for NDA: 021483

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006► Subscribe► Subscribe
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
Boehringer Ingelheim
Baxter
Fish and Richardson
Deloitte
Federal Trade Commission
UBS
Citi
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot